SCHEMBL447733

SCHEMBL447733

O=CCn1ccnc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28188435 0.98
SCHEMBL7413663 0.84 TBXAS1 (0.40)
SCHEMBL10529099 0.81
SCHEMBL31135789 0.77
SCHEMBL2001148 0.77
SCHEMBL31135787 0.77
SCHEMBL2884168 0.76
SCHEMBL29004014 0.76
SCHEMBL83887 0.76
SCHEMBL16371567 0.76 TBXAS1 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111229311-B Supported imidazole ionic liquid catalyst and method for synthesizing 2-amino-3-cyano-4H-pyran compounds 三峡大学 2022-03-18 CN claimed
CN-111229311-A Supported imidazole ionic liquid catalyst and method for synthesizing 2-amino-3-cyano-4H-pyran compounds 三峡大学 2020-06-05 CN claimed
EP-0149115-A2 Derivatives of 2-(1-imidazolyl)-ethanol BOEHRINGER INGELHEIM KG (DE) 1985-07-24 EP claimed
US-4492795-A Alkylcycloalkyl imidazolylmethyl ketones as fungicide intermediates BAYER AKTIENGESELLSCHAFT (DE) 1985-01-08 US claimed
CN-113226326-B Organic compound 细胞内治疗公司 2024-09-20 CN disclosed
CN-114805462-B Steroid derivative regulator and preparation method and application thereof 江苏豪森药业集团有限公司 2024-06-18 CN disclosed
US-11987772-B2 Solvent composition CENTRAL GLASS COMPANY, LIMITED (JP) 2024-05-21 US disclosed
CN-114656514-B Steroid derivative regulator and preparation method and application thereof 江苏豪森药业集团有限公司 2024-05-14 CN disclosed
US-20240043777-A1 Composition; Cleaning Agent, Aerosol Composition, Draining Agent, Foaming Agent, or Heat-Transfer Medium Containing the Composition; System Using the Heat-Transfer Medium; And Method of Cleaning Articles CENTRAL GLASS CO., LTD. (JP) 2024-02-08 US disclosed
EP-3325496-B1 METHOD OF PREPARING PHYSIOLOGICALLY ACTIVE POLYPEPTIDE CONJUGATE HANMI PHARM IND CO LTD (KR) 2024-02-07 EP disclosed
CN-112638928-B Salt of steroid derivative regulator and crystal form thereof 上海翰森生物医药科技有限公司 2023-12-22 CN disclosed
WO-2023159035-A1 NEUROACTIVE STEROIDS FOR TREATMENT OF CNS-RELATED DISORDERS SAGE THERAPEUTICS, INC. (US) 2023-08-24 WO disclosed
US-6339099-B1 FOR THERAPY AND PROPHYLAXIS OF THROMBOEMBOLIC DISORDER DUPONT PHARMACEUTICALS COMPANY 2002-01-15 US disclosed
CN-1214685-A Farnesyl protein transfer inhibitors BRISTOL MYERS SQUIBB CO (US) 1999-04-21 CN disclosed
CN-1112117-A Imidazole-containing inhibitors of farnesyl protein transferase BRISTOL MYERS SQUIBB CO (US) 1995-11-22 CN disclosed
US-4767868-A 3-Phenyl-3-(1H-imidazol-1-ylmethyl)-2-methyl-5-[(phenylamino)methyl]isoxazolidines PENNWALT CORPORATION (US) 1988-08-30 US disclosed
US-4550175-A REACTING 2,4-DICHLOROBENZYL CHLORIDE WITH 1-(2,4-DICHLOROPHENYL)-2(IMIDAZOL-1-YL)-ETHANONE OXIME SIEGFRIED AKTIENGESELLSCHAFT (CH) 1985-10-29 US disclosed
US-4492795-A Alkylcycloalkyl imidazolylmethyl ketones as fungicide intermediates BAYER AKTIENGESELLSCHAFT (DE) 1985-01-08 US disclosed
US-4443612-A REACTION OF A HALOKETONE WITH IMIDAZOLE AND HYDROXYLAMINE SIEGFRIED AKTIENGESELLSCHAFT (CH) 1984-04-17 US disclosed
US-3949076-A GASTRIC ACID SECRETION INHIBITION SMITHKLINE CORPORATION (US) 1976-04-06 US disclosed